|
Diabetic retinopathy clinical practice guidelines: Customized for Iranian population
Zhale Rajavi MD 1, Sare Safi MS 1, Mohammad Ali Javadi MD 2, Mohsen Azarmina MD 2, Siamak Moradian MD 3, Morteza Entezari MD 3, Ramin Nourinia MD 2, Hamid Ahmadieh MD 2, Armin Shirvani MD 4, Saeid Shahraz MD, PhD 5, Alireza Ramezani MD 6, Mohammad Hossein Dehghan MD 7, Mohsen Shahsavari MD 8, Masoud Soheilian MD 9, Homayoun Nikkhah MD 10, Hossein Ziaei MD 1, Hasan Behboudi MD 11,Fereydoun Farrahi MD 12, Khalil Ghasemi Falavarjani MD 13, Mohammad Mehdi Parvaresh MD 13, Hamid Fesharaki MD 14, Majid Abrishami MD 15, Nasser Shoeibi MD 15, Mansour Rahimi MD 16, Alireza Javadzadeh MD 17, Reza Karkhaneh MD 18, Mohammad Riazi-Esfahani MD 18, Masoud Reza Manaviat MD 19, Alireza Maleki MD 20, Bahareh Kheiri MS 2, Faegheh Golbafian MD 21
1 Ophthalmic Research Center; Ophthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Ophthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Standardization and CPG Development Office, Deputy of Curative Affairs, Ministry of Health and Medical Education, Tehran, Iran
5 Tufts Medical Center, Boston, Massachusetts, USA
6 Ophthalmic Epidemiology Research Center; Department of Ophthalmology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7 Ophthalmic Epidemiology Research Center; Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
8 Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
9 Ophthalmic Research Center; Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
10 Ophthalmic Research Center; Department of Ophthalmology, Torfeh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
11 Department of Ophthalmology, Gilan University of Medical Sciences, Rasht, Iran
12 Department of Ophthalmology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
13 Department of Ophthalmology, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
14 Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran
15 Department of Ophthalmology, Mashhad University of Medical Sciences, Mashhad, Iran
16 Department of Ophthalmology, Shiraz University of Medical Sciences, Shiraz, Iran
17 Department of Ophthalmology, Tabriz University of Medical Sciences, Tabriz, Iran
18 Department of Ophthalmology, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
19 Department of Ophthalmology, Yazd University of Medical Sciences, Yazd, Iran
20 Department of Ophthalmology, Al Zahra Eye Center, Zahedan University of Medical Sciences, Zahedan, Iran
21 Victoria Family Medical Centre, UWO, London, ON, Canada
|
| |
|
Purpose: To customize clinical practice guidelines (CPGs) for management of diabetic retinopathy (DR) in the Iranian population. Methods:Three DR CPGs (The Royal College of Ophthalmologists 2013, American Academy of Ophthalmology [Preferred Practice Pattern 2012], and Australian Diabetes Society 2008) were selected from the literature using the AGREE tool. Clinical questions were designed and summarized into four tables by the customization team. The components of the clinical questions along with pertinent recommendations extracted from the above-mentioned CPGs; details of the supporting articles and their levels of evidence; clinical recommendations considering clinical benefits, cost and side effects; and revised recommendations based on customization capability (applicability, acceptability, external validity) were recorded in 4 tables, respectively. Customized recommendations were sent to the faculty members of all universities across the country to score the recommendations from 1 to 9. Results: Agreed recommendations were accepted as the final recommendations while the non-agreed ones were approved after revision. Eventually, 29 customized recommendations under three major categories consisting of screening, diagnosis and treatment of DR were developed along with their sources and levels of evidence.Conclusion: This customized CPGs for management of DR can be used to standardize the referral pathway, diagnosis and treatment of patients with diabetic retinopathy. |
|
http://www.jovr.org/article.asp?issn=2008-322X;year=2016;volume=11;issue=4;spage=394;epage=414;aulast=Rajavi;type=0
|
